Atossa Therapeutics Inc.
ATOS | NASDAQ
$2.29
+$0.04 (+1.78%)
Sep 22, 2026, 2:15 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 8K | 8K | 4K | 8K | 8K | 12K | 17K | 27K | 26K | 25K | 23K | 11K | 10K | 9K | 8K | 7.74K | 11.95K | 15.75K | 23K | 30.52K | 36.86K | 43.45K |
Gross Profit | -8K | -8K | -4K | -8K | -8K | -12K | -17K | -27K | -26K | -25K | -23K | -11K | -10K | -9K | -8K | -7.74K | -11.95K | -15.75K | -23K | -30.52K | -36.86K | -43.45K |
Operating Income | -30.56M | -39.6M | -37.14M | -32.86M | -29.99M | -28.06M | -27.62M | -29.49M | -30.57M | -31.26M | -31.38M | -30.5M | -31.23M | -30.04M | -27.69M | -24.38M | -21.33M | -21.74M | -20.52M | -19.92M | -18.27M | -15.2M |
Interest Income | 1.55M | 1.97M | 2.38M | 2.77M | 3.2M | 3.63M | 4.05M | 4.45M | 4.72M | 4.63M | 4.34M | 3.98M | 2.9M | 1.93M | 1.08M | 206K | 12K | 1K | n/a | n/a | n/a | n/a |
Pretax Income | -37.71M | -37.64M | -34.77M | -30.18M | -28.72M | -26.34M | -25.5M | -26.91M | -25.91M | -29.69M | -30.09M | -29.83M | -31.61M | -28.46M | -26.96M | -24.3M | -21.49M | -21.85M | -20.61M | -23.26M | -21.55M | -18.42M |
Net Income | -37.71M | -37.64M | -34.77M | -30.18M | -28.72M | -26.34M | -25.5M | -26.91M | -25.91M | -29.69M | -30.09M | -29.83M | -31.61M | -28.46M | -26.96M | -24.3M | -21.49M | -21.85M | -20.61M | -23.26M | -21.55M | -18.42M |
Selling & General & Admin | 18.04M | 17.78M | 15.95M | 14.42M | 13.52M | 13.53M | 13.5M | 13.1M | 13.13M | 13.67M | 14.03M | 13.83M | 13.88M | 12.95M | 12.61M | 12.46M | 12.36M | 12.41M | 11.31M | 10.18M | 9.08M | 8.15M |
Research & Development | 21.2M | 21.81M | 21.19M | 18.43M | 16.47M | 14.53M | 14.12M | 16.37M | 17.42M | 17.57M | 17.33M | 15.9M | 16.6M | 16.32M | 14.32M | 11.97M | 9.19M | 9.67M | 9.65M | 10.13M | 9.41M | 7.16M |
Other Expenses | n/a | n/a | n/a | -4K | -4K | -4K | -4K | n/a | n/a | n/a | n/a | 763K | 763K | 763K | 763K | -50K | -227K | -336K | -443K | -393K | -216K | -107K |
Operating Expenses | 39.24M | 39.59M | 37.14M | 32.85M | 29.99M | 28.05M | 27.61M | 29.47M | 30.55M | 31.24M | 31.36M | 30.5M | 31.23M | 30.04M | 27.69M | 24.38M | 21.33M | 21.74M | 20.52M | 19.92M | 18.27M | 15.2M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 820K | 820K | 820K | 820K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -8K | -8K | -4K | -4K | n/a | n/a | -5K | -5K | -5K | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.56M | 39.6M | 37.14M | 32.86M | 29.99M | 28.06M | 27.62M | 29.49M | 30.57M | 31.26M | 31.38M | 30.5M | 31.23M | 30.04M | 27.69M | 24.38M | 21.33M | 21.74M | 20.52M | 19.92M | 18.27M | 15.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 8.91M | 8.62M | 8.61M | 8.61M | 8.61M | 8.61M | 8.44M | 8.38M | 8.38M | 8.35M | 8.35M | 8.39M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.1M | 6.17M |
Shares Outstanding (Diluted) | 8.91M | 8.62M | 8.61M | 8.61M | 8.61M | 8.61M | 8.44M | 8.38M | 8.38M | 8.35M | 8.35M | 8.39M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.44M | 8.1M | 6.17M |
EPS (Basic) | -4.34 | -4.37 | -4.04 | -3.52 | -3.37 | -3.12 | -3.04 | -3.22 | -3.10 | -3.54 | -3.58 | -3.54 | -3.75 | -3.37 | -3.19 | -2.88 | -2.55 | -2.62 | -2.63 | -3.27 | -7.75 | -13.33 |
EPS (Diluted) | -4.34 | -4.37 | -4.04 | -3.52 | -3.37 | -3.12 | -3.04 | -3.22 | -3.10 | -3.54 | -3.58 | -3.54 | -3.75 | -3.37 | -3.19 | -2.88 | -2.55 | -2.62 | -2.63 | -3.27 | -7.75 | -13.33 |
EBITDA | -29.21M | -37.63M | -34.75M | -30.16M | -28.7M | -26.33M | -25.49M | -26.88M | -25.88M | -29.67M | -30.07M | -29.82M | -31.6M | -28.45M | -26.95M | -24.29M | -21.48M | -21.84M | -20.58M | -19.96M | -18.27M | -15.16M |
EBIT | -29.22M | -37.64M | -34.77M | -30.18M | -28.72M | -26.34M | -25.5M | -26.91M | -25.91M | -29.69M | -30.09M | -29.83M | -31.61M | -28.46M | -26.96M | -24.3M | -21.49M | -21.85M | -20.6M | -19.99M | -18.3M | -15.2M |
Depreciation & Amortization | 12K | 16K | 16K | 16K | 16K | 16K | 17K | 27K | 26K | 25K | 23K | 11K | 10K | 9K | 8K | 8K | 12K | 16K | 23K | 30.74K | 37.29K | 43.67K |
Add to Watchlist
Select watchlists to add or remove ATOS